2022 Q1 Form 10-Q Financial Statement

#000143774922011629 Filed on May 10, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q1
Revenue $3.352M $2.177M
YoY Change 53.97% 93.4%
Cost Of Revenue $661.6K $460.5K
YoY Change 43.69% 102.71%
Gross Profit $2.690M $1.717M
YoY Change 56.73% 91.05%
Gross Profit Margin 80.26% 78.85%
Selling, General & Admin $1.086M $936.0K
YoY Change 16.07% -0.19%
% of Gross Profit 40.38% 54.53%
Research & Development $0.00 $8.839K
YoY Change -100.0% -54.25%
% of Gross Profit 0.0% 0.51%
Depreciation & Amortization $2.950K $7.430K
YoY Change -60.3% -46.78%
% of Gross Profit 0.11% 0.43%
Operating Expenses $1.086M $944.8K
YoY Change 14.98% -1.28%
Operating Profit $1.604M $780.5K
YoY Change 105.48% -2085.67%
Interest Expense $40.91K $47.98K
YoY Change -14.74% -17.43%
% of Operating Profit 2.55% 6.15%
Other Income/Expense, Net $10.61K
YoY Change
Pretax Income $1.655M $828.5K
YoY Change 99.8% 4305.55%
Income Tax $393.5K $212.5K
% Of Pretax Income 23.77% 25.65%
Net Earnings $1.262M $616.0K
YoY Change 104.84% -6142.84%
Net Earnings / Revenue 37.65% 28.3%
Basic Earnings Per Share $0.28 $0.14
Diluted Earnings Per Share $0.27 $0.14
COMMON SHARES
Basic Shares Outstanding 4.522M 4.501M
Diluted Shares Outstanding 4.596M 4.505M

Balance Sheet

Concept 2022 Q1 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $5.700M $2.984M
YoY Change 91.0% 147.68%
Cash & Equivalents $5.660M $2.946M
Short-Term Investments $39.96K $37.64K
Other Short-Term Assets $1.013M $252.5K
YoY Change 301.23% -4.49%
Inventory $1.308M $1.530M
Prepaid Expenses $1.013M $252.5K
Receivables $1.280M $1.467M
Other Receivables $0.00 $0.00
Total Short-Term Assets $9.301M $6.234M
YoY Change 49.2% 12.81%
LONG-TERM ASSETS
Property, Plant & Equipment $4.927K $23.42K
YoY Change -78.96% -81.07%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $127.1K $224.1K
YoY Change -43.27%
Other Assets $0.00
YoY Change
Total Long-Term Assets $997.7K $446.4K
YoY Change 123.5% -83.73%
TOTAL ASSETS
Total Short-Term Assets $9.301M $6.234M
Total Long-Term Assets $997.7K $446.4K
Total Assets $10.30M $6.680M
YoY Change 54.17% -19.22%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $193.1K $150.6K
YoY Change 28.2% 1.18%
Accrued Expenses $59.77K $118.7K
YoY Change -49.65% -3.0%
Deferred Revenue $1.310M $245.9K
YoY Change 432.59%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.320M $626.5K
YoY Change 270.34% 11.38%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $473.4K
YoY Change -100.0%
Other Long-Term Liabilities $112.4K $5.620K
YoY Change 1899.11% -99.79%
Total Long-Term Liabilities $112.4K $473.4K
YoY Change -76.27% -82.1%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.320M $626.5K
Total Long-Term Liabilities $112.4K $473.4K
Total Liabilities $2.496M $1.358M
YoY Change 83.84% -62.76%
SHAREHOLDERS EQUITY
Retained Earnings $6.030M $3.674M
YoY Change 64.15%
Common Stock $2.006M $1.882M
YoY Change 6.58%
Preferred Stock
YoY Change
Treasury Stock (at cost) $233.6K $233.6K
YoY Change 0.0%
Treasury Stock Shares $134.7K $134.7K
Shareholders Equity $7.803M $5.323M
YoY Change
Total Liabilities & Shareholders Equity $10.30M $6.680M
YoY Change 54.17% -19.22%

Cashflow Statement

Concept 2022 Q1 2021 Q1
OPERATING ACTIVITIES
Net Income $1.262M $616.0K
YoY Change 104.84% -6142.84%
Depreciation, Depletion And Amortization $2.950K $7.430K
YoY Change -60.3% -46.78%
Cash From Operating Activities $713.9K $798.2K
YoY Change -10.56% -1453.82%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 -$57.00K
YoY Change -100.0%
Cash From Investing Activities $0.00 -$57.00K
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $0.00 $473.4K
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities $713.9K $798.2K
Cash From Investing Activities $0.00 -$57.00K
Cash From Financing Activities $0.00 $473.4K
Net Change In Cash $713.9K $1.215M
YoY Change -41.22% -2160.1%
FREE CASH FLOW
Cash From Operating Activities $713.9K $798.2K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
4621988
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
61376 USD
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
61376 USD
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4656734
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4656734
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4621988
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4521988
CY2022Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
134746
CY2021Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
134746
CY2022Q1 tbtc Number Of Contracts Of Collectable Revenue
NumberOfContractsOfCollectableRevenue
1 USD
CY2022Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
36353 USD
CY2021Q1 us-gaap Lessor Sales Type Lease Term Of Contract1
LessorSalesTypeLeaseTermOfContract1
P5Y
CY2022Q1 us-gaap Open Tax Year
OpenTaxYear
2017 2018 2019 2020
CY2022Q1 us-gaap Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Amount Of Unrecorded Benefit
SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit
0 USD
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5659781 USD
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4945913 USD
CY2022Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1279672 USD
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1017533 USD
CY2022Q1 us-gaap Inventory Net
InventoryNet
1308430 USD
CY2021Q4 us-gaap Inventory Net
InventoryNet
1582358 USD
CY2022Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1013111 USD
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
799524 USD
CY2022Q1 tbtc Salestype Lease Net Investment In Lease After Allowance For Credit Loss Current
SalestypeLeaseNetInvestmentInLeaseAfterAllowanceForCreditLossCurrent
39962 USD
CY2021Q4 tbtc Salestype Lease Net Investment In Lease After Allowance For Credit Loss Current
SalestypeLeaseNetInvestmentInLeaseAfterAllowanceForCreditLossCurrent
39369 USD
CY2022Q1 us-gaap Assets Current
AssetsCurrent
9300956 USD
CY2021Q4 us-gaap Assets Current
AssetsCurrent
8384697 USD
CY2022Q1 us-gaap Accounts Receivable Net Noncurrent
AccountsReceivableNetNoncurrent
706031 USD
CY2021Q4 us-gaap Accounts Receivable Net Noncurrent
AccountsReceivableNetNoncurrent
288665 USD
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4927 USD
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7879 USD
CY2022Q1 tbtc Salestype Lease Net Investment In Lease After Allowance For Credit Loss Noncurrent
SalestypeLeaseNetInvestmentInLeaseAfterAllowanceForCreditLossNoncurrent
127122 USD
CY2021Q4 tbtc Salestype Lease Net Investment In Lease After Allowance For Credit Loss Noncurrent
SalestypeLeaseNetInvestmentInLeaseAfterAllowanceForCreditLossNoncurrent
137337 USD
CY2022Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
0 USD
CY2021Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
9000 USD
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
159587 USD
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
174096 USD
CY2022Q1 us-gaap Assets Noncurrent
AssetsNoncurrent
997667 USD
CY2021Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
616977 USD
CY2022Q1 us-gaap Assets
Assets
10298623 USD
CY2021Q4 us-gaap Assets
Assets
9001674 USD
CY2022Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
193122 USD
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
258764 USD
CY2022Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
12685 USD
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
26370 USD
CY2022Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1309500 USD
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1576000 USD
CY2022Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
47088 USD
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
51046 USD
CY2022Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
757972 USD
CY2021Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
438022 USD
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
2320367 USD
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2350202 USD
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
112351 USD
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
124114 USD
CY2022Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
63000 USD
CY2021Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
0 USD
CY2022Q1 us-gaap Liabilities
Liabilities
2495718 USD
CY2021Q4 us-gaap Liabilities
Liabilities
2474316 USD
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
4622 USD
CY2022Q1 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-319950 USD
CY2021Q1 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-208600 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
713868 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
798172 USD
CY2022Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
-0 USD
CY2021Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
57000 USD
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1655340 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
828507 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
5322506 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
6527358 USD
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
13707 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
1261840 USD
CY2021Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1000 USD
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
13707 USD
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
13006 USD
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
679505 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
295680 USD
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
4522 USD
CY2022Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2001744 USD
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1988137 USD
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
6030138 USD
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
4768298 USD
CY2022Q1 us-gaap Stockholders Equity Before Treasury Stock
StockholdersEquityBeforeTreasuryStock
8036504 USD
CY2021Q4 us-gaap Stockholders Equity Before Treasury Stock
StockholdersEquityBeforeTreasuryStock
6760957 USD
CY2022Q1 us-gaap Treasury Stock Value
TreasuryStockValue
233599 USD
CY2021Q4 us-gaap Treasury Stock Value
TreasuryStockValue
233599 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
7802905 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
6527358 USD
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
10298623 USD
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
9001674 USD
CY2022Q1 us-gaap Revenues
Revenues
3351834 USD
CY2021Q1 us-gaap Revenues
Revenues
2176973 USD
CY2022Q1 us-gaap Cost Of Revenue
CostOfRevenue
661622 USD
CY2021Q1 us-gaap Cost Of Revenue
CostOfRevenue
460460 USD
CY2022Q1 us-gaap Gross Profit
GrossProfit
2690212 USD
CY2021Q1 us-gaap Gross Profit
GrossProfit
1716513 USD
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1086396 USD
CY2021Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
935985 USD
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
1603816 USD
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
780528 USD
CY2022Q1 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
10611 USD
CY2021Q1 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
0 USD
CY2022Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
40913 USD
CY2021Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
47979 USD
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
393500 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
212500 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
1261840 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
616007 USD
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.28
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.14
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.27
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.14
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4521988
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4500672
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4596037
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4505132
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
4693493 USD
CY2021Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
13006 USD
CY2021Q1 us-gaap Stock Issued During Period Value Treasury Stock Reissued
StockIssuedDuringPeriodValueTreasuryStockReissued
0 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
616007 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
7802905 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
1261840 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
616007 USD
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2952 USD
CY2021Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
7426 USD
CY2022Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
72000 USD
CY2022Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-273928 USD
CY2021Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-218400 USD
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
213587 USD
CY2021Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-58670 USD
CY2022Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-9622 USD
CY2021Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
204724 USD
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-66854 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
45319 USD
CY2022Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-13685 USD
CY2021Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
47982 USD
CY2022Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-266500 USD
CY2021Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
82166 USD
CY2021Q4 tbtc Receivable Employee Retention Credit
ReceivableEmployeeRetentionCredit
122000 USD
CY2021Q1 tbtc Salestype Lease Net Investment In Lease After Allowance For Credit Loss
SalestypeLeaseNetInvestmentInLeaseAfterAllowanceForCreditLoss
210782 USD
CY2021Q1 tbtc Inventory Derecognized For Sales Type Leases
InventoryDerecognizedForSalesTypeLeases
139521 USD
CY2022Q1 us-gaap Sales Type Lease Lease Income
SalesTypeLeaseLeaseIncome
9622 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-57000 USD
CY2022Q1 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
0 USD
CY2021Q1 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
473400 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
473400 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
713868 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1214572 USD
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4945913 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1731869 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
5659781 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2946441 USD
CY2022Q1 us-gaap Stock Issued1
StockIssued1
0 USD
CY2021Q1 us-gaap Stock Issued1
StockIssued1
12047 USD
CY2022Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
15340 USD
CY2021Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
14504 USD
CY2022Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin: 0pt; text-align: left;"/> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin: 0pt; text-align: left;"><span style="text-decoration: underline; ">Use of Estimates</span></p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin: 0pt; text-align: left;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin: 0pt; text-align: justify;">The preparation of financial statements in conformity with U.S. generally accepted accounting principles (GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. The Company’s use of estimates and assumptions include: for revenue recognition, the nature and timing of satisfaction of performance obligations, and determining the standalone selling price (“SSP”) of performance obligations, determining collectability, and other obligations, realizability of accounts receivable, the valuation of investments, the valuation of deferred tax assets and liabilities, and inventory valuation. Actual results could differ from those estimates, and the difference could be significant.  For further information about our critical accounting estimates, see the discussion in Item <em style="font: inherit;">7,</em> “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” under the heading “Critical Accounting Policies and Estimates” in the Company’s Annual Report on Form <em style="font: inherit;">10</em>-K for the year ended <em style="font: inherit;"> December 31, 2021.</em></p> <hr style="height: 1px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 3pt 0"/> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">There were <em style="font: inherit;">no</em> changes in critical accounting estimates or assumptions for the <em style="font: inherit;">three</em> months ended <em style="font: inherit;"> March 31, 2022.</em></p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin: 0pt; text-align: left;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin: 0pt; text-align: justify;">The Company’s significant accounting policies are described in Note <em style="font: inherit;">1</em> of the financial statement included in its Annual Report on Form <em style="font: inherit;">10</em>-K for the year ended <em style="font: inherit;"> December 31, 2021</em>.</p>
CY2022Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin: 0pt; text-align: justify;"/> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin: 0pt; text-align: justify;"><span style="text-decoration: underline; ">Concentrations of Risk</span></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">The Company maintains its cash balances at <em style="font: inherit;">two</em> financial institutions. Accounts are insured by the Federal Deposit Insurance Corporation (FDIC) up to <em style="font: inherit;">$250,000.</em> At times throughout the year, the Company’s cash balances exceeded amounts insured by the FDIC. The Company doesn’t believe it is exposed to any significant credit risk on its cash balances.  Cash equivalents represent money market funds or short-term investments with original maturities of <em style="font: inherit;">three</em> months or less from the date of purchase.</p>
CY2022Q1 us-gaap Revenues
Revenues
3351834 USD
CY2021Q1 us-gaap Revenues
Revenues
2176973 USD
CY2022Q1 tbtc Percent Of Revenues
PercentOfRevenues
1.000 pure
CY2021Q1 tbtc Percent Of Revenues
PercentOfRevenues
1.000 pure
CY2022Q1 us-gaap Contract With Customer Asset Accumulated Allowance For Credit Loss
ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss
280268 USD
CY2021Q1 us-gaap Contract With Customer Asset Accumulated Allowance For Credit Loss
ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss
1438136 USD
CY2022Q1 tbtc Revenue Recognized On Contract With Customer
RevenueRecognizedOnContractWithCustomer
1078685 USD
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
61376 USD
CY2022Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1279672 USD
CY2021Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
36353 USD
CY2022Q1 us-gaap Inventory Net
InventoryNet
1308430 USD
CY2021Q4 us-gaap Inventory Net
InventoryNet
1582358 USD
CY2022Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
81310 USD
CY2021Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
699024 USD
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1017533 USD
CY2022Q1 us-gaap Accounts Receivable Net Noncurrent
AccountsReceivableNetNoncurrent
706031 USD
CY2021Q4 us-gaap Accounts Receivable Net Noncurrent
AccountsReceivableNetNoncurrent
288665 USD
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
61376 USD
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
61376 USD
CY2021Q1 tbtc Lessor Salestype Lease Implied Interest Rate
LessorSalestypeLeaseImpliedInterestRate
0.06 pure
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
0 USD
CY2021Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8839 USD
CY2022Q1 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
1276115 USD
CY2021Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
1078909 USD
CY2022Q1 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
64933 USD
CY2021Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
0 USD
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
61376 USD
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
61376 USD
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
77623 USD
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable Period Increase Decrease
AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
0 USD
CY2021 us-gaap Allowance For Doubtful Accounts Receivable Period Increase Decrease
AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
0 USD
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
-0 USD
CY2021 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
16247 USD
CY2021Q1 us-gaap Sales Type Lease Lease Income
SalesTypeLeaseLeaseIncome
71261 USD
CY2022Q1 us-gaap Sales Type Lease Interest Income
SalesTypeLeaseInterestIncome
2603 USD
CY2021Q1 us-gaap Sales Type Lease Interest Income
SalesTypeLeaseInterestIncome
6057 USD
CY2022Q1 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Remainder Of Fiscal Year
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedRemainderOfFiscalYear
36675 USD
CY2022Q1 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Next Twelve Months
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedNextTwelveMonths
48900 USD
CY2022Q1 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Two Years
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedTwoYears
48900 USD
CY2022Q1 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Three Years
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedThreeYears
48900 USD
CY2022Q1 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Four Years
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedFourYears
4075 USD
CY2022Q1 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived
187450 USD
CY2022Q1 us-gaap Sales Type And Direct Financing Leases Lease Receivable Undiscounted Excess Amount
SalesTypeAndDirectFinancingLeasesLeaseReceivableUndiscountedExcessAmount
20366 USD
CY2022Q1 us-gaap Sales Type And Direct Financing Leases Lease Receivable
SalesTypeAndDirectFinancingLeasesLeaseReceivable
167084 USD
CY2022Q1 tbtc Salestype Lease Net Investment In Lease After Allowance For Credit Loss
SalestypeLeaseNetInvestmentInLeaseAfterAllowanceForCreditLoss
167084 USD
CY2021Q4 tbtc Salestype Lease Net Investment In Lease After Allowance For Credit Loss
SalestypeLeaseNetInvestmentInLeaseAfterAllowanceForCreditLoss
176706 USD
CY2022Q1 tbtc Salestype Lease Net Investment In Lease After Allowance For Credit Loss Current
SalestypeLeaseNetInvestmentInLeaseAfterAllowanceForCreditLossCurrent
39962 USD
CY2021Q4 tbtc Salestype Lease Net Investment In Lease After Allowance For Credit Loss Current
SalestypeLeaseNetInvestmentInLeaseAfterAllowanceForCreditLossCurrent
39369 USD
CY2022Q1 tbtc Salestype Lease Net Investment In Lease After Allowance For Credit Loss Noncurrent
SalestypeLeaseNetInvestmentInLeaseAfterAllowanceForCreditLossNoncurrent
127122 USD
CY2021Q4 tbtc Salestype Lease Net Investment In Lease After Allowance For Credit Loss Noncurrent
SalestypeLeaseNetInvestmentInLeaseAfterAllowanceForCreditLossNoncurrent
137337 USD
CY2022Q1 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.05 pure
CY2022Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
15430 USD
CY2021Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
14504 USD
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
41900 USD
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
50566 USD
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
51582 USD
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
26045 USD
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
170093 USD
CY2022Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
10654 USD
CY2022Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
159439 USD
CY2022Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y2M23D
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
70000
CY2021Q2 tbtc Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue
128726 USD
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
15000
CY2021Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
22919 USD
CY2022Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
85000
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y1M20D
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.52
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
88050 USD
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
32500
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
2.69
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
28200 USD
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
85000
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
0
CY2022Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 USD
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1261840 USD
CY2021Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
616007 USD
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4521988
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4500672
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.28
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.14
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4596037
CY2022Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
74049
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4505132
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.27
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.14

Files In Submission

Name View Source Status
0001437749-22-011629-index-headers.html Edgar Link pending
0001437749-22-011629-index.html Edgar Link pending
0001437749-22-011629.txt Edgar Link pending
0001437749-22-011629-xbrl.zip Edgar Link pending
ex_354364.htm Edgar Link pending
ex_354365.htm Edgar Link pending
ex_354366.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tbltrc20220331b_10q.htm Edgar Link pending
tbltrc20220331b_10q_htm.xml Edgar Link completed
tbtc-20220331.xsd Edgar Link pending
tbtc-20220331_cal.xml Edgar Link unprocessable
tbtc-20220331_def.xml Edgar Link unprocessable
tbtc-20220331_lab.xml Edgar Link unprocessable
tbtc-20220331_pre.xml Edgar Link unprocessable